JP2022553540A5 - - Google Patents
Info
- Publication number
- JP2022553540A5 JP2022553540A5 JP2022523913A JP2022523913A JP2022553540A5 JP 2022553540 A5 JP2022553540 A5 JP 2022553540A5 JP 2022523913 A JP2022523913 A JP 2022523913A JP 2022523913 A JP2022523913 A JP 2022523913A JP 2022553540 A5 JP2022553540 A5 JP 2022553540A5
- Authority
- JP
- Japan
- Prior art keywords
- treg
- chain
- tcr
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201915344A GB201915344D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory T cell |
| GB1915347.7 | 2019-10-23 | ||
| GB201915341A GB201915341D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory T cell |
| GB201915360A GB201915360D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915362A GB201915362D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915362.6 | 2019-10-23 | ||
| GB1915341.0 | 2019-10-23 | ||
| GB201915354A GB201915354D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915348.5 | 2019-10-23 | ||
| GB201915351A GB201915351D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915357A GB201915357D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915366.7 | 2019-10-23 | ||
| GB201915348A GB201915348D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB201915347A GB201915347D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915351.9 | 2019-10-23 | ||
| GB1915354.3 | 2019-10-23 | ||
| GB1915360.0 | 2019-10-23 | ||
| GB201915366A GB201915366D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| GB1915357.6 | 2019-10-23 | ||
| GB1915344.4 | 2019-10-23 | ||
| PCT/GB2020/052659 WO2021079122A1 (en) | 2019-10-23 | 2020-10-22 | Engineered regulatory t cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553540A JP2022553540A (ja) | 2022-12-23 |
| JP2022553540A5 true JP2022553540A5 (https=) | 2023-10-19 |
Family
ID=73040143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523913A Pending JP2022553540A (ja) | 2019-10-23 | 2020-10-22 | 操作された制御性ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220364057A1 (https=) |
| EP (1) | EP4048294A1 (https=) |
| JP (1) | JP2022553540A (https=) |
| CN (1) | CN114641564B (https=) |
| AU (1) | AU2020370033A1 (https=) |
| CA (1) | CA3154606A1 (https=) |
| WO (1) | WO2021079122A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023050063A1 (zh) * | 2021-09-28 | 2023-04-06 | 溧阳瑅赛生物医药有限公司 | 一种识别hla-a*02:01/e629-38的tcr及其应用 |
| EP4568686A2 (en) * | 2022-08-12 | 2025-06-18 | Abata Therapeutics, Inc. | Cell therapies for multiple sclerosis |
| WO2024039576A2 (en) * | 2022-08-19 | 2024-02-22 | Memorial Sloan-Kettering Cancer Center | T cell receptors targeting ras mutations and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| GB0917094D0 (en) * | 2009-09-29 | 2009-11-11 | Ucl Biomedica Plc | T-cell receptor |
| US10093901B2 (en) * | 2013-05-10 | 2018-10-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Use of specific regulatory T-cells to induce immune tolerance |
| WO2016133779A1 (en) * | 2015-02-16 | 2016-08-25 | The Trustees Of The University Of Pennsylvania | A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein |
-
2020
- 2020-10-22 WO PCT/GB2020/052659 patent/WO2021079122A1/en not_active Ceased
- 2020-10-22 EP EP20800254.3A patent/EP4048294A1/en active Pending
- 2020-10-22 JP JP2022523913A patent/JP2022553540A/ja active Pending
- 2020-10-22 CA CA3154606A patent/CA3154606A1/en active Pending
- 2020-10-22 CN CN202080076993.4A patent/CN114641564B/zh not_active Expired - Fee Related
- 2020-10-22 AU AU2020370033A patent/AU2020370033A1/en not_active Abandoned
- 2020-10-22 US US17/771,466 patent/US20220364057A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520831A5 (https=) | ||
| JP2022502371A5 (https=) | ||
| JP2022553540A5 (https=) | ||
| BR112022001923A2 (pt) | Proteína de ligação ao antígeno, ácido nucleico isolado, célula hospedeira recombinante, composição farmacêutica, método de produção da proteína de ligação ao antígeno | |
| JP2021526816A5 (https=) | ||
| JP2024522357A5 (https=) | ||
| JP2021520198A5 (https=) | ||
| JP2020511152A5 (https=) | ||
| JP2020500523A5 (https=) | ||
| JP2019511222A5 (https=) | ||
| JP2020511115A5 (https=) | ||
| FI4219542T3 (fi) | T-solureseptoreja | |
| TW201827460A (zh) | 改善配對的ｔ細胞受體 | |
| JP2020511936A5 (https=) | ||
| JP2012095650A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| JPWO2020059847A5 (https=) | ||
| IL308831A (en) | T cell receptors | |
| JP2020502996A5 (https=) | ||
| JP2023524788A5 (https=) | ||
| UA101603C2 (ru) | Гуманизированное антитело к фактору d и его применение | |
| JP2013505734A5 (https=) | ||
| JP2007530435A5 (https=) | ||
| JP2022505585A5 (https=) | ||
| JP2020530777A (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2023522799A5 (https=) |